Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 4
1965 2
1966 1
1968 1
1969 3
1970 6
1971 4
1972 1
1974 1
1975 1
1976 1
1977 2
1978 1
1979 1
1980 2
1981 1
1982 3
1983 7
1984 5
1985 6
1986 1
1987 2
1988 1
1989 5
1990 1
1991 1
1992 2
1993 2
1994 2
1995 1
1998 2
1999 1
2000 2
2001 1
2003 1
2004 3
2005 1
2007 1
2008 2
2009 2
2010 1
2011 1
2012 2
2013 2
2014 4
2016 2
2017 4
2018 7
2019 9
2020 7
2021 7
2022 5
2023 10
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

141 results

Results by year

Filters applied: . Clear all
Page 1
Brief Report: Canadian Cancer Trials Group IND.227: A Phase 2 Randomized Study of Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma (NCT02784171).
Piccirillo MC, Chu Q, Bradbury P, Tu W, Coschi CH, Grosso F, Florescu M, Mencoboni M, Goffin JR, Pagano M, Ciardiello F, Cecere FL, Vincent M, Ferrara R, Dawe DE, Hao D, Lee CW, Morabito A, Gridelli C, Cavanna L, Iqbal M, Blais N, Leighl NB, Wheatley-Price P, Tsao MS, Ugo F, El-Osta H, Gargiulo P, Gaudreau PO, Tu D, Sederias J, Brown-Walker P, Perrone F, Seymour L, Laurie SA. Piccirillo MC, et al. Among authors: dawe de. J Thorac Oncol. 2023 Jun;18(6):813-819. doi: 10.1016/j.jtho.2023.02.003. Epub 2023 Feb 24. J Thorac Oncol. 2023. PMID: 36841541 Clinical Trial.
Pembrolizumab plus chemotherapy versus chemotherapy in untreated advanced pleural mesothelioma in Canada, Italy, and France: a phase 3, open-label, randomised controlled trial.
Chu Q, Perrone F, Greillier L, Tu W, Piccirillo MC, Grosso F, Lo Russo G, Florescu M, Mencoboni M, Morabito A, Cecere FL, Ceresoli GL, Dawe DE, Zucali PA, Pagano M, Goffin JR, Sanchez ML, Gridelli C, Zalcman G, Quantin X, Westeel V, Gargiulo P, Delfanti S, Tu D, Lee CW, Leighl N, Sederias J, Brown-Walker P, Luo Y, Lantuejoul S, Tsao MS, Scherpereel A, Bradbury P, Laurie SA, Seymour L. Chu Q, et al. Among authors: dawe de. Lancet. 2023 Dec 16;402(10419):2295-2306. doi: 10.1016/S0140-6736(23)01613-6. Epub 2023 Nov 3. Lancet. 2023. PMID: 37931632 Clinical Trial.
Immune Signatures of Non-Small Cell Lung Cancer.
Green S, Dawe DE, Banerji S. Green S, et al. Among authors: dawe de. J Thorac Oncol. 2017 Jun;12(6):913-915. doi: 10.1016/j.jtho.2017.04.008. J Thorac Oncol. 2017. PMID: 28532560 Free article. No abstract available.
Brain metastases in non-small-cell lung cancer.
Dawe DE, Greenspoon JN, Ellis PM. Dawe DE, et al. Clin Lung Cancer. 2014 Jul;15(4):249-57. doi: 10.1016/j.cllc.2014.04.008. Epub 2014 May 13. Clin Lung Cancer. 2014. PMID: 24954227 Review.
Children's needs in shelters: mother's perceptions.
Bennett L, Dawe D, Power J. Bennett L, et al. Among authors: dawe d. Can J Commun Ment Health. 1999 Spring;18(1):57-76. doi: 10.7870/cjcmh-1999-0004. Can J Commun Ment Health. 1999. PMID: 10847987 Free article. Review.
141 results